- Selected to join BLUE KNIGHT™
- Featured in The New Yorker: The Long Quest for Artificial Blood
- Qualified Maryland Biotech Company (QMBC) for State Biotech Investment Initiative Tax Credit (BIITC)
- Subcontract for DARPA FSHARP renewed for Year 3
- Team expanded to 11 employees
